Vimarsana
Biggest News Aggregation in the World

Reference Genome Database News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Reference Genome Database. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Reference Genome Database Today - Breaking & Trending Today

Microbiotica Announces Clinical Trial Collaboration with MSD to Evaluate MB097 in Combination with KEYTRUDA (pembrolizumab) in a Phase 1b Clinical Trial in Melanoma - Vimarsana News

Microbiotica Announces Clinical Trial Collaboration with MSD to Evaluate MB097 in Combination with KEYTRUDA (pembrolizumab) in a Phase 1b Clinical Trial in Melanoma

Published: April 12, 2023

Microbiotica, a leader in discovering and developing microbiome-based therapeutics and biomarkers, today announces it has entered into a clinical trial collaboration with MSD (Merck Co., Inc., Rahway

Source: finanznachrichten.de
Related Topics:
United StatesUnited KingdomRo GardnerTim SharpingtonSanger InstituteIp GroupChesterford Research ParkMerck Sharp DohmeMerck Co IncPersonalised Bacterial BankCytotoxict LymphocyteReference Genome DatabaseCulture CollectionBritish Patient CapitalCambridge Innovation CapitalFlerie InvestSeventure Partners
Microbiotica Announces Transition of Leadership - Vimarsana News

Microbiotica Announces Transition of Leadership

Published: November 29, 2022

Co-founder and CEO Mike Romanos steps down after six years to take up role of Associate Dean of Enterprise in the Faculty of Medicine at Imperial College Tim Sharpington, Microbiotica COO

Source: finanznachrichten.de
Related Topics:
United KingdomCity OfGiulia Lasagni Batoul AliGordon DouganTim SharpingtonTrevor LawleyRo GardnerKostenloser WertpapierhandelMelanie Toyne Sewell Agnes StephensHans SchikanSanger InstituteFaculty Of Medicine At Imperial CollegeChesterford Research ParkWellcome Sanger InstitutePersonalised Bacterial BankIp GroupAssociate DeanMike RomanosChief Operating OfficerImperial CollegeReference Genome DatabaseCulture CollectionBritish Patient CapitalCambridge Innovation CapitalFlerie Invest
Microbiotica Raises £50m ($67m) to Advance Pipeline of Microbiome-based Therapeutics - Vimarsana News

Microbiotica Raises £50m ($67m) to Advance Pipeline of Microbiome-based Therapeutics

Published: March 7, 2022

Microbiotica Raises £50m ($67m) to Advance Pipeline of Microbiome-based Therapeutics - read this article along with other careers information, tips and advice on BioSpace

Source: biospace.com
Related Topics:
United StatesHong KongUnited KingdomCity OfSam WilliamsCarl Johan SpakRobert TansleyThomas ElderedSanger InstitutePrudential Regulation AuthorityUniversity Of CambridgeIp GroupUniversity Of AdelaideCambridge University HospitalsMain Market Of The London Stock ExchangeFinancial Conduct AuthorityChesterford Research ParkWellcome Sanger InstitutePartner Of Life SciencesBritish Patient CapitalPersonalised Bacterial BankCancer Research United KingdomBritish Business BankHealth For Life CapitalFlerie Invest